Fachliteratur Gastroenterologie: Neoplasien Pankreas

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie

11. November 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 3107


	Artikel 1 - 20 / 62137

	Randomized multicentre Phase 2 clinical trial of non-viral gene therapy for pancreatic cancer: clinical and molecular findings. Cancer Drug Resist Buscail L, Lebrin M, Hanoun N, Gourgou S, Dorat N, Vernejoul F, Cambois G, Gross F, Guimbaud R, Bournet B, Mitry E, Artru P, Ouvrier D, Flori N, Thuillier F, Barthet M, Tiraby M, Cordelier P, Thergap-2 Investigator Group. PMID: 43011677 [PubMed]
	Sex and Etiology Differences in Overall Survival and Adverse Liver Events in Hepatocellular Carcinoma: An International Multicenter Study. MedComm (2020) Xia F, Huang H, Guo B, Xu M, Gasque RA, Chen Q, Zhang Q, Wu Z, Chen W, Huang Z, Liu Y, Liu L, Han S, He S, Li D, Xiang B, Zhou C, Zhou W, Li Y, Lu S, Jiang C, Duan X, Liao Y, Gu J, Zhou B, Cai W, Zhang J, Yin H, Xia G, Wan Y, Li J, Xia X, Sun H, Wang S, Chen Y, Yuan F, Lin F, Cai W, Gao H, Ren L, Chen X, Geng T, Giannone F, Moctezuma-Velazquez C, Zhang E, Andraus W, Cheng Q, Zhang Z. PMID: 43011222 [PubMed]
	Awareness of the signs and symptoms of pancreatic cancer: a cross-sectional study from a developing country setting. Future Sci OA Rataan AO, Amawi H, Alsous M, Alrosan AZ, Albawaana A, Alzoubi KH. PMID: 43010177 [PubMed]
	Stimuli-responsive CRISPR-based genome editing delivery system for cancer treatment: A review of fundamentals and applications. J Control Release Jiang Y, Sun R, Zhang J, Wang C, Chen X, Wu D. PMID: 43009024 [PubMed - as supplied by publisher]
	Robotic pancreatic enucleation versus laparoscopic pancreatic enucleation: a meta-analysis. J Robot Surg Shi J, Zhu C, Zhou Y. PMID: 43007558 [PubMed - indexed for MEDLINE]
	Targeting lipid metabolism to overcome immunosuppression and enhance immunotherapy or chemotherapy sensitivity in pancreatic cancer: from immunosuppressive mechanisms to therapeutic opportunities. Mol Biol Rep Zhan T, Liu Y, Yan J, Huang X. PMID: 43007394 [PubMed - indexed for MEDLINE]
	Implementation of a rapid onsite molecular adequacy protocol for endoscopic ultrasound-guided sampling of pancreatic ductal adenocarcinoma. Cancer Cytopathol Gao Y, Canty C, Prakash LR, Coronel E, Katz MHG, Snyder RA, Roy-Chowdhuri S. PMID: 43006245 [PubMed - indexed for MEDLINE]
	Predicting complications after hepatectomy for hepatocellular carcinoma: a narrative review focused on liver failure. Front Oncol Zhang H, Cai J, Yang Z, Ye T, Zhao Z, Chen X, Wan J. PMID: 43005667 [PubMed]
	CT referrals and cancer detection in patients referred by general practitioners with non-specific symptoms and signs of cancer: A retrospective study. Acta Radiol Open Ohana NL, Axelsen J, Wilkinson MS, Graumann O, Sivesgaard K, Buus TW, Vedsted P, Midtgaard A, Greve SB, Larsen SKA. PMID: 43005528 [PubMed]
	Current and emerging strategies to enhance chemotherapeutic efficacy in pancreatic ductal adenocarcinoma. BMC Med Hackett D, Kane LE, Prina-Mello A, Maher SG. PMID: 43004418 [PubMed - indexed for MEDLINE]
	Exercise-containing multimodal prehabilitation on functional outcome of patients with hepatobiliary and pancreatic cancer after surgery: a meta-analysis. BMC Cancer She Z, Jiang Q, Lu W. PMID: 43004285 [PubMed - indexed for MEDLINE]
	Ras signaling in cancer: From molecular mechanisms to next-generation therapeutic inhibitors. Biochim Biophys Acta Rev Cancer Hossain J, Choudhury D, Bhattacharyya S, Vedeshachaitanya B, Malakar P. PMID: 43003238 [PubMed - as supplied by publisher]
	Controversies in NEN: An ENETS position statement on the diagnosis and treatment of mixed neuroendocrine/non-neuroendocrine neoplasms of the digestive system. J Neuroendocrinol Spada F, Kasajima A, de Mestier L, Luong TV, Marinoni I, Milione M, Sadanandam A, Speel EJ, Koumarianou A, Caruso D, Pascher A, Sorbye H. PMID: 43003098 [PubMed - indexed for MEDLINE]
	Towards precision oncology in pancreatic cancer: Diagnostic and prognostic biomarkers from conventional methods to liquid biopsy and artificial intelligence-based approaches. Biochem Biophys Res Commun Maghsoodi N, Ameri M, Absalan F, Esmaeili M, Ramezani A. PMID: 43002872 [PubMed - as supplied by publisher]
	Cancer Risks Associated With Germline BARD1 Pathogenic/Likely Pathogenic Variants: A Multicenter Study of 445 Families. JCO Precis Oncol Homer JP, Demeure MJ, Yao Y, Hanson K, Ramczyk B, Lichtenberg EC, Cohen SA, Crow K, Florido ME, Powell KP, Koerner CM, DeGrandchamp ME, Zrada C, Gonzales MB, Collier RA, Chien ES, Torres CB, Lin J, Sigsbee S, Smith SG, Adar TA, Berry DK, Gewandter K, Wright N, Senter L, Brown J, Baker MJ, Morse K, Scouten R, Brown SM, van den Berg D, Tran LB, Childers K, Gordon O, Bond E, Pagan B, Woo S, Mandich H, Nathan D, Karlan BY, Ku L, De Rosa D, Chang EY, Reed L, Brown EB, Patel G, Darabi S, BARD1 Collaborators. PMID: 43002722 [PubMed - indexed for MEDLINE]
	PancreaGuide for Computed Tomography Report Interpretation and Perioperative Consultation in Pancreatic Cancer: Development and Retrospective Evaluation of a Knowledge-Augmented Large Language Model Agent. J Med Internet Res Kuang T, Wang R, Zhang S, Sun Y, Zhou J, Wu Z, Peng B. PMID: 43002664 [PubMed - indexed for MEDLINE]
	Ecosystem Determinants of Therapeutic Resistance in Pancreatic Cancer: Implications for Precision Oncology. Cancer Invest Shahiwala AF. PMID: 43001337 [PubMed - as supplied by publisher]
	RNA sequencing and proteomic analysis of diagnostic biopsies from colorectal and pancreatic cancer. Biochem Biophys Rep Nordlund V, Haram M, Hofsli E, Røe OD, Davies CL, Mjelle R. PMID: 43001289 [PubMed]
	New-Onset Diabetes as a Red Flag for Pancreatic Cancer: From Metabolic Clues to Earlier Detection in Primary Care. Cureus Camacho-Flores L, Alvarez A, Bonet Vazquez R, Benet P, Alfonso García CB, Marti Del Rio M. PMID: 43001179 [PubMed]
	Quantitative fragility of reported association between aspirin use and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: Letter to the editor on "Aspirin and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: Nationwide cohort study with genetic risk analysis". Clin Mol Hepatol Zhang SJ, Gao G. PMID: 43001021 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 62137

Seite 1 von 3107



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung